‘Neurogenic inflammation’—the release of pro-inflammatory mediators such as Substance P, calcitonin gene-related peptide (CGRP), and calcitonin and endothelin—might assist to the progression and the pain of tendinopathy [91]. This evidence concerns the gene TAC1 and disease of the tendon.